Yissum - Research Development Company of the Hebrew University

Diagnostic test for epilepsy in Arabian horses

Posted by Yissum - Research Development Company of the Hebrew UniversityResponsive · Innovative Products and Technologies · Israel

Summary of the technology


Project ID : 24-2017-4415

Yissum - Research Development Company of the Hebrew University

Description of the technology

An accurate DNA test for identifying potential carriers of Juvenile Idiopathic Epilepsy in Arabian Horses


Arabian horses, Arab horses, horse breeding, blood horse, horse sperm, equine semen, artificial insemination in horses, horse testing, equine industry, equine testing, equine genetic testing services, horse DNA testing, horse genetic testing, horse veterinary genetics lab, genetic disorders in horses,idiopathic epilepsy in horses, Juvenile Idiopathic Epilepsy (JIE), Juvenile Epilepsy Syndrome (JES), veterinary neurology, horse seizures, horse-breed registry, studbook, Arabian Horse Association (AHA), U.S. Equestrian Federation (USEF), horse shows.

Development Stage

Clinical proof of concept and initial results

Patent Status

Provisional patent application filed

Innovation summary

Our innovation comprises a simple, low-cost test, both for female and male horses of any age, detecting Juvenile Idiopathic Epilepsy (JIE) - a genetic disease exclusive to Arabian horses. Accurate results are provided within several days. If a carrier is identified, owners can outbreed the horse to minimize the chance of the defective gene appearing in successive generations, sparing pain and suffering of off-springs. In addition, horse breeders can avoid the risk of purchasing a horse or semen bearing the inherited disorder, saving considerable cultivation and breeding expenses.

The onset of the disorder is commonly from birth to 6 months, and the symptoms often recede by 1-2 years of age - when the foal becomes fertile. Nevertheless, the foal continues to pass on the defective gene. Physiological symptoms include seizures of varying intensities, causing severe secondary injuries, temporary loss of consciousness, disorientation, intermittent blindness, and secondary aspiration pneumonia. Convulsions are commonly controlled by administering phenobarbital for several months.

The Arabian horse industry involves sizable amounts of money, whereby horses are bred to compete in endurance racing and horse shows, as well as for prestige and leisure, or as pets. There is an increasing demand in this industry for genetic testing – now a mandatory requirement for registering horses in the U.S. Arabian Horse Association (AHA) studbook.


The test kit, containing several test tubes and reagents, utilizes real-time polymerase chain reaction (PCR) technology - a platform that enables quick and accurate detection of the specific genetic markers of the disease. A blood or hair sample are taken from either a female or male horse, in order to extract and test its DNA. A short, simple procedure is implemented to detect the genetic markers, and test results are available within a few days.


  • Low-cost, accurate and fast diagnostic tool
  • Spares breeders purchasing and cultivation expenses
  • Minimizes suffering of horses
  • Tool for advancing genetic research
  • Enables the gradual outbreeding of potential carriers

Development milestones

After having conducted extensive research on the Arabian horse population in Israel, we found a high correlation between two genetic markers in the horse’s genome and the incidence of the disorder.

Another research project on Arabian horses which is currently underway – soon to be published by the Hebrew University - will enable the detection of a horse’s breed purity, as well as screening for additional genetic diseases with known genetic predispositions.


  • Purchase the technology license
  • Use the diagnostic lab service
  • Testing by veterinarian clinics
  • Testing provided to horse owners, buyers and breeders

Researcher information:https://www.linkedin.com/in/sagi-polani-9b614628/



Project manager

Amichai Baron
VP, Head of Business Development, Agritech & Envir

Project researchers

Gila Kahila Bar-Gal
HUJI, Faculty of Agricultural, Food and Environmental Quality Sciences
The Koret School of Veterinary Medicine

HUJI, Faculty of Agricultural, Food and Environmental Quality Sciences
The Koret School of Veterinary Medicine

Related keywords

  • Medicine, Human Health
  • Biology / Biotechnology
  • Genome Research
  • Micro- and Nanotechnology related to Biological sciences
  • Veterinary Medicine
  • Monoclonal Antibodies and Hybridomas
  • Gene Splicing and Manufacturing Equipment
  • Other Genetic Engineering
  • Molecular design Market
  • Microbiology Market
  • Toxicology Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Population genetics Market
  • Other Medical/Health Related
  • Agro and Marine biotech
  • Anatomy, Pathology, Immunology, Physiology
  • Clinical Medicine
  • Animal health
  • Express Licensing
  • agriculture

About Yissum - Research Development Company of the Hebrew University

Technology Transfer Office from Israel

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Send your request

By clicking "Send your request" you are signing up and accepting our Terms of Service and Privacy policy

Technology Offers on Innoget are directly posted and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.